Extracellular Vesicles as Biomarkers and Therapeutics for Inflammatory Eye Diseases.

Mol Pharm

Buchanan Ocular Therapeutics Unit, Department of Ophthalmology, New Zealand National Eye Centre, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.

Published: January 2023

AI Article Synopsis

Article Abstract

Extracellular vesicles (EVs) are a group of cell-derived membrane vesicles of varying sizes that can be secreted by most cells. Depending on the type of cell they are derived from, EVs may contain a variety of cargo including proteins, lipids, miRNA, and DNA. Functionally, EVs play important roles in physiological and pathological processes through intercellular communication. While there has already been significant literature on the involvement of EVs in neurological and cardiovascular disease as well as cancer, recent evidence suggests that EVs may also play a role in mediating inflammatory eye diseases. This paper summarizes current advancements in ocular EV research as well as new ways by which EVs may be utilized as novel biomarkers of or therapeutics for inflammatory eye diseases.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.molpharmaceut.2c00414DOI Listing

Publication Analysis

Top Keywords

inflammatory eye
12
eye diseases
12
extracellular vesicles
8
biomarkers therapeutics
8
therapeutics inflammatory
8
evs play
8
evs
6
vesicles biomarkers
4
diseases extracellular
4
vesicles evs
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!